Gapping down
In reaction to disappointing earnings/guidance:
- MITK -11.8% (Mitek Systems CEO Jim DeBello will be transitioning out of his role; co reaffirms full-year guidance), PAHC -8.4%, BBY -3.7%, BJ -2.5%, CTLT -2%
Other news:
- AKCA -26.5% (Akcea Therapeutics and Ionis receive Complete Response Letter for WAYLIVRA from FDA)
- IONS -12.5% (Akcea Therapeutics and Ionis receive Complete Response Letter for WAYLIVRA from FDA)
- WMGI -4.1% (prices offering of 18,248,932 of its ordinary shares at $24.60 per share)
- EDIT -2.5% (Chief Medical Officer Gerald Cox, M.D., Ph.D. will be stepping down from the Company at the end of the year)
Analyst comments:
- LASR -5.6% (initiated with a Sell at The Benchmark Company; tgt $17)
- SBGL -4% (downgraded to Underperform from Neutral at Macquarie)
- AMSWA -2.9% downgraded to Neutral at B. Riley FBR)
- CTRL -2.1% (downgraded to In-line at Imperial Capital)
- HMY -1.7% (downgraded to Underperform from Neutral at Macquarie)
- AMAT -1.4% (downgraded to Neutral from Buy at BofA/Merrill)
- LRCX -1.1% (downgraded to Neutral from Buy at BofA/Merrill)
![]()